These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. An extremely aggressive case of Marburg's disease treated with high dose cyclophosphamide. A case report. Avila-Ornelas J; Labat E; Alfonso G; Serrano C; Fiorito F Mult Scler Relat Disord; 2019 Jun; 31():51-53. PubMed ID: 30925320 [TBL] [Abstract][Full Text] [Related]
8. Multiple sclerosis: long-term remission after a high dose of cyclophosphamide. de Bittencourt PR; Gomes-da-Silva MM Acta Neurol Scand; 2005 Mar; 111(3):195-8. PubMed ID: 15691289 [TBL] [Abstract][Full Text] [Related]
9. Acute tumefactive demyelinating lesions in a pediatric patient with known diagnosis of multiple sclerosis: review of the literature and treatment proposal. Dastgir J; DiMario FJ J Child Neurol; 2009 Apr; 24(4):431-7. PubMed ID: 19189932 [TBL] [Abstract][Full Text] [Related]
10. [Acute posterior cord lesions in multiple sclerosis. An MRI study of the clinical course in 20 cases]. Pou Serradell A; Roquer González J; Perich Alsina X Rev Neurol (Paris); 2000 Dec; 156(12):1126-35. PubMed ID: 11139729 [TBL] [Abstract][Full Text] [Related]
11. [Treatment of multifocal motor neuropathies]. Azulay JP; Pouget J; Rihet P; Serratrice G Rev Neurol (Paris); 1996 May; 152(5):380-2. PubMed ID: 8881434 [TBL] [Abstract][Full Text] [Related]
12. [Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up]. Askenazy F; Dor E; Benoit M; Dupuis G; Serret S; Myquel M; Seddiki Y Encephale; 2010 Feb; 36(1):46-53. PubMed ID: 20159196 [TBL] [Abstract][Full Text] [Related]
13. [Serial magnetic resonance imaging of spinal syrinx formation in a case of multiple sclerosis]. Ando T; Kameyama T; Kawai K; Fukatsu H; Takahashi A Rinsho Shinkeigaku; 1992 Nov; 32(11):1288-93. PubMed ID: 1301334 [TBL] [Abstract][Full Text] [Related]
14. A second case of Marburg's variant of multiple sclerosis with vasculitis and extensive demyelination. Elenein RG; Sharer LR; Cook SD; Pachner AR; Michaels J; Hillen ME Mult Scler; 2011 Dec; 17(12):1531-8. PubMed ID: 21816761 [TBL] [Abstract][Full Text] [Related]
15. Current disease-modifying therapies in multiple sclerosis. Kieseier BC; Hartung HP Semin Neurol; 2003 Jun; 23(2):133-46. PubMed ID: 12894379 [TBL] [Abstract][Full Text] [Related]
16. Successful treatment of a patient with severe Churg-Strauss syndrome by a combination of pulse corticosteroids, pulse cyclophosphamide, and high-dose intravenous immunoglobulin. Takigawa N; Kawata N; Shibayama T; Tada A; Kimura G; Munemasa M; Soda R; Takahashi K J Asthma; 2005 Oct; 42(8):639-41. PubMed ID: 16266953 [TBL] [Abstract][Full Text] [Related]
17. Case Report: Successful Stabilization of Marburg Variant Multiple Sclerosis With Ocrelizumab Following High-Dose Cyclophosphamide Rescue. Koska V; Förster M; Brouzou K; Hatami M; Arat E; Aytulun A; Albrecht P; Aktas O; Küry P; Meuth SG; Kremer D Front Neurol; 2021; 12():696807. PubMed ID: 34248832 [TBL] [Abstract][Full Text] [Related]
18. A double blind, placebo-controlled, phase II, add-on study of cyclophosphamide (CTX) for 24 months in patients affected by multiple sclerosis on a background therapy with interferon-beta study denomination: CYCLIN. Patti F; Amato MP; Filippi M; Gallo P; Trojano M; Comi GC J Neurol Sci; 2004 Aug; 223(1):69-71. PubMed ID: 15261564 [TBL] [Abstract][Full Text] [Related]